This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Amlodipine
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| - | <StructureSection load='' size='340' side='right' caption=' | + | <StructureSection load='' size='340' side='right' caption='Amlodipine' scene='10/1017441/Cv/1'> |
Amlodipine, sold under the brand name Norvasc among others, is a [[Voltage-gated calcium channels|calcium channel]] blocker medication used to treat high blood pressure, coronary artery disease (CAD)<ref name="a10">[https://www.drugs.com/monograph/amlodipine.html "Amlodipine Besylate".] Drugs.com. American Society of Hospital Pharmacists. Archived from the original on 4 June 2016. Retrieved 22 July 2016.</ref> See also [https://en.wikipedia.org/wiki/Amlodipine Amlodipine]. | Amlodipine, sold under the brand name Norvasc among others, is a [[Voltage-gated calcium channels|calcium channel]] blocker medication used to treat high blood pressure, coronary artery disease (CAD)<ref name="a10">[https://www.drugs.com/monograph/amlodipine.html "Amlodipine Besylate".] Drugs.com. American Society of Hospital Pharmacists. Archived from the original on 4 June 2016. Retrieved 22 July 2016.</ref> See also [https://en.wikipedia.org/wiki/Amlodipine Amlodipine]. | ||
Current revision
| |||||||||||
References
- ↑ "Amlodipine Besylate". Drugs.com. American Society of Hospital Pharmacists. Archived from the original on 4 June 2016. Retrieved 22 July 2016.
- ↑ Ananchenko G, Novakovic J, Lewis J. Amlodipine besylate. Profiles Drug Subst Excip Relat Methodol. 2012;37:31-77. PMID:22469316 doi:10.1016/B978-0-12-397220-0.00002-7
- ↑ "Amlodipine". www.drugbank.ca. Archived from the original on 31 January 2019. Retrieved 30 January 2019.
- ↑ Clusin WT, Anderson ME. Calcium channel blockers: current controversies and basic mechanisms of action. Adv Pharmacol. 1999;46:253-96. PMID:10332505 doi:10.1016/s1054-3589(08)60473-1
